Stock screener

CRNX

Conviction 80HealthcareScan · Mon, Aug 10, 2026
CRNX$84.17+0.11%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
2
Vol MA14 2.71M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Crinetics Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.crinetics.com ↗
Price84.17
Change+0.11%
Gap-0.10%
Rel volume0.57×
Avg volume3.09M
Avg $ vol259.43M
SMA 2083.84
SMA 5059.74
SMA 20047.26
Price vs 50+40.90%
Price vs 200+78.12%
MA stackbullish
50/200 cross—
Supertrendup · 82.04
RSI (14)90
MACD hist-1.68
MACD cross—
Stoch %K / %D80 / 76
ADX (14)76
+DI / −DI64 / 6
RSI divergence—
MACD divergence—
ATR %+1.19%
ADR %0.27%
52w high84.17
52w low26.85
From 52w high+0.00%
Above 52w low+213.48%
New 52w highYes
SqueezeOff
Bollinger width0.71%
%B1.05
Donchian pos80.00%
Donchian high84.35
Donchian low83.47
AVWAP (52w high)84.17
vs AVWAP high+0.00%
AVWAP (52w low)57.09
vs AVWAP low+47.44%
OBV trendUp
Chaikin MF (20)-0.28
Today vs 20d0.57×
Avg vol (14d)2.71M
Avg vol (20d)3.09M
Avg $ vol (20d)259.43M
Market cap8.93B
RS 3m (vs SPY)+87.63%
RS 6m (vs SPY)+73.61%
RS line new highNo
Trend template8/8
Technical rank86.5
1 week+0.49%
1 month+0.71%
3 months+124.57%
6 months+85.89%
1 year+201.90%
YTD+80.12%
P/E-19.19
P/B7.49
P/S—
P/FCF-23.27
EPS-4.95
Div yield—
ROE-39.04%
ROA-35.20%
Debt/Eq—
Current15.57
EV/EBITDA-17.30
Gross margin—
Net margin—
Rev growth640.71%
EPS growth-55.93%
Price target85.56
Target upside1.65%
Analyst ratingHold
Institutional125.27%
Ent. value8.87B
Revenue25.12M
Net income-120.86M
Gross profit—
Free cash flow-383.68M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out105.44M
Employees594
ListedWed, Jul 18, 2018
Free float100.71M
Float %95.5%
Short interest6.21M
Days to cover0.5d
Short volume12.2%
Squeeze score15 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.14 vs −$1.23
Last surprise+7.3% beat
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank86.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance84.00
Support59.09
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CRNX · 5 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-03-03
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-04-17
Buy$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · D · NJ · traded 2025-03-19
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-01-29
Buy$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · NJ · traded 2024-09-25
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in CRNX · 9 buys · 1 sell

InsiderSideShares
Vivaldi Coelho Rogerio
Director · Common Stock · 2026-07-02
Sell3K
Fust Matthew K
Director · Stock Option (Right to Buy) · 2026-06-18
Grant9.73K
Deardorf Caren
Director · Common Stock · 2026-06-18
Grant5.92K
Deardorf Caren
Director · Stock Option (Right to Buy) · 2026-06-18
Grant9.73K
Okey Stephanie
Director · Common Stock · 2026-06-18
Grant5.92K
Okey Stephanie
Director · Stock Option (Right to Buy) · 2026-06-18
Grant9.73K
WIERENGA WENDELL
Director · Common Stock · 2026-06-18
Grant5.92K
Bedrosian Camille L
Director · Common Stock · 2026-06-18
Grant5.92K
Bedrosian Camille L
Director · Stock Option (Right to Buy) · 2026-06-18
Grant9.73K
WIERENGA WENDELL
Director · Stock Option (Right to Buy) · 2026-06-18
Grant9.73K

SEC filings

EDGAR filings in CRNX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.